PYC Therapeutics | PYC - Sales Revenues

Stock Price
1.50
Daily Change
0.01 0.33%
Monthly
-9.64%
Yearly
19.05%
Q1 Forecast
1.47

PYC Therapeutics reported AUD13.48M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Avita Medical AUD 18.42M 14K Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025